BML-259
BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
Product Specifications
CAS Number
267654-00-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
260.36
Molecular Formula
C14H16N2OS
Notes
Research use only, not for human use.
Receptor
Antifungal|Antiviral
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
